We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSGS icon
2551
Madison Square Garden
MSGS
$9.57B
$0 ﹤0.01%
4
– –
MUX icon
2552
McEwen Inc
MUX
$1.04B
$0 ﹤0.01%
20
– –
NET icon
2553
Cloudflare
NET
$94.3B
– –
-1,200
Closed -$22
NGD
2554
DELISTED
New Gold Inc
NGD
$0 ﹤0.01%
272
– –
NMM icon
2555
Navios Maritime Partners
NMM
$2.21B
– –
-1
Closed –
NRT
2556
North European Oil Royalty Trust
NRT
$79.2M
– –
-5,000
Closed -$30
NWG icon
2557
NatWest
NWG
$72.8B
$0 ﹤0.01%
8
– –
OCSL icon
2558
Oaktree Specialty Lending
OCSL
$1.04B
– –
-15
Closed –
OMER icon
2559
Omeros
OMER
$821M
$0 ﹤0.01%
37
– –
ONCY
2560
Oncolytics Biotech
ONCY
$95.5M
– –
-210
Closed –
ONEV icon
2561
State Street SPDR Russell 1000 Low Volatility Focus ETF
ONEV
$304M
– –
-200
Closed -$16
PJT icon
2562
PJT Partners
PJT
$4.36B
$0 ﹤0.01%
10
– –
PNNT
2563
Pennant Park Investment Corp
PNNT
$219M
– –
-40
Closed –
PSEC icon
2564
Prospect Capital
PSEC
$1.12B
– –
-15
Closed –
PSP icon
2565
Invesco Global Listed Private Equity ETF
PSP
$230M
– –
-300
Closed -$17
PTC icon
2566
PTC
PTC
$14.5B
– –
-47
Closed -$3
QRVO icon
2567
Qorvo
QRVO
$7.92B
$0 ﹤0.01%
3
– –
RARE icon
2568
Ultragenyx Pharmaceutical
RARE
$2.65B
$0 ﹤0.01%
14
– –
RIG icon
2569
Transocean
RIG
$5.84B
– –
-1,100
Closed -$4
RMCF icon
2570
Rocky Mountain Chocolate Factory
RMCF
$8.03M
– –
-1,176
Closed -$10
RMR icon
2571
The RMR Group
RMR
$348M
$0 ﹤0.01%
1
– –
ROKU icon
2572
Roku
ROKU
$21.2B
$0 ﹤0.01%
+7
New +$962
ROM icon
2573
ProShares Ultra Technology
ROM
$1.11B
– –
-64
Closed –
RUSHA icon
2574
Rush Enterprises Class A
RUSHA
$5.98B
– –
-473
Closed -$8
RYAM icon
2575
Rayonier Advanced Materials
RYAM
$573M
$0 ﹤0.01%
254
– –
101 102
103
104 105

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.